Navigating chemical space for biology and medicine

@article{Lipinski2004NavigatingCS,
  title={Navigating chemical space for biology and medicine},
  author={Christopher A. Lipinski and Andrew L. Hopkins},
  journal={Nature},
  year={2004},
  volume={432},
  pages={855-861}
}
Despite over a century of applying organic synthesis to the search for drugs, we are still far from even a cursory examination of the vast number of possible small molecules that could be created. Indeed, a thorough examination of all ‘chemical space’ is practically impossible. Given this, what are the best strategies for identifying small molecules that modulate biological targets? And how might such strategies differ, depending on whether the primary goal is to understand biological systems… 

Figures and Tables from this paper

Towards the systematic exploration of chemical space.
TLDR
Synthetic strategies that have emerged that may allow chemical space to be explored more systematically are described, with particular emphasis on approaches that allow the scaffolds of small molecules to be varied combinatorially.
The chemist as astronaut: searching for biologically useful space in the chemical universe.
  • D. Triggle
  • Chemistry, Biology
    Biochemical pharmacology
  • 2009
Practical strategies for small-molecule probe development in chemical biology.
TLDR
This chapter provides practical tools for identifying and developing promising screening hit compounds into effective tools for biological discovery.
Chemical probes and drug leads from advances in synthetic planning and methodology
TLDR
This article focuses on strategies such as diversity-oriented synthesis that aim to explore novel areas of chemical space efficiently by populating small-molecule libraries with compounds containing structural features that are typically under-represented in commercially available screening collections.
Smart Design of Small‐Molecule Libraries: When Organic Synthesis Meets Cheminformatics
TLDR
This minireview focuses on novel cheminformatics approaches used to design molecular scaffolds, as well as to analyze their quality, giving a perspective of them in the field of chemical biology and drug discovery through some selected case studies.
Informatics: Exploring pharmacological space
TLDR
The authors propose a refinement of the concept of druggability beyond Lipinski’s rule-of-five, by considering how the ligand properties of known active compounds for protein targets can be used to derive probabilistic approaches to determining ‘degrees’ of Druggability, relative to oral drug space.
Privileged structures: efficient chemical "navigators" toward unexplored biologically relevant chemical spaces.
TLDR
The development of privileged substructure-based DOS (pDOS), an efficient strategy for the construction of polyheterocyclic compound libraries with high biological relevancy, and the capability of privileged structures to serve as chemical "navigators" toward biologically relevant chemical spaces are presented.
Bioactivity-guided navigation of chemical space.
TLDR
The research is presented at linking chemical and biological space to define suitable starting points that guide the synthesis of compound collections with biological relevance, which is essential for the frequent identification of small molecules with diverse biological activities.
Diversity-oriented synthesis as a tool for the discovery of novel biologically active small molecules.
TLDR
Diversity-oriented synthesis (DOS) aims to generate structural diversity in an efficient manner through the screening of small-molecule libraries for the discovery of novel, biologically interesting small molecules.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 75 REFERENCES
The druggable genome
An assessment of the number of molecular targets that represent an opportunity for therapeutic intervention is crucial to the development of post-genomic research strategies within the pharmaceutical
From magic bullets to designed multiple ligands.
Small-molecule inhibitors of protein–protein interactions: progressing towards the dream
TLDR
Here, illustrative examples are used to discuss general strategies for addressing the challenges inherent in the discovery and characterization of small-molecule inhibitors of protein–protein interactions.
Tethering: fragment-based drug discovery.
TLDR
The background and theory behind Tethering is described and its use in identifying novel inhibitors for protein targets including interleukin-2 (IL-2), thymidylate synthase (TS), protein tyrosine phosphatase 1B (PTP-1B), and caspases is discussed.
Chemical space navigation in lead discovery.
  • T. Oprea
  • Chemistry
    Current opinion in chemical biology
  • 2002
Biochemical mechanisms of drug action: what does it take for success?
  • D. Swinney
  • Biology
    Nature Reviews Drug Discovery
  • 2004
TLDR
Potential drug discovery and development risks associated with the biochemical mechanism of drug action are addressed, and simple rules to minimize these risks are proposed.
Prediction of 'drug-likeness'.
Molecular Complexity and Its Impact on the Probability of Finding Leads for Drug Discovery
TLDR
The hypothesis that less complex molecules are more common starting points for the discovery of drugs is supported by the changes observed for these properties during the drug optimization phase.
...
1
2
3
4
5
...